Ravel Biotechnology
San Francisco, USA
|
Description:
Ravel Biotechnology is developing an AI-enabled diagnostic platform to detect diseases. The platform uses artificial intelligence technology to analyze the epigenomic profiles in cell-free DNA to identify the damaged or diseased cells which are used to diagnose the diseases.
Ravel Biotechnology is developing an AI-enabled diagnostic platform to detect diseases. The platform uses artificial intelligence technology to analyze the epigenomic profiles in cell-free DNA to identify the damaged or diseased cells which are used to diagnose the diseases.